首頁 > 市場調查報告書 > 醫療設備

體外診斷

市場調查報告書

商品編碼

1634155

全球體外受精 (IVF) 服務市場 - 2025 - 2032

Global In Vitro Fertilization (IVF) Services Market - 2025 - 2032

出版日期: 2025年01月13日 | 出版商:

DataM Intelligence | 英文 176 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2024年，全球體外受精（IVF）服務市場規模達249.1億美元，預計2032年將達到480.4億美元，2025-2032年預測期間複合年成長率為8.6%。

體外受精 (IVF) 服務是一種透過在體外（通常在實驗室環境中）將卵子與精子結合來促進受精的醫療程序。 “體外”一詞翻譯為“在玻璃中”，表示受精過程發生在受控環境中，而不是在人體內。 IVF過程通常由幾個關鍵步驟組成，包括卵巢刺激、取卵、受精、胚胎培養和胚胎移植。

體外受精服務通常用於解決各種不孕原因，包括高齡產婦、輸卵管阻塞、男性因素不孕、子宮內膜異位症和不明原因不孕。對於許多面臨與生育相關的挑戰而尋求懷孕的夫婦來說，該手術已成為一個重要的選擇。這些因素擴大了全球體外受精（IVF）服務市場。

市場動態：

驅動程式和限制

不孕症發生率增加

不孕症發生率的增加極大地推動了全球體外受精（IVF）服務市場的成長，預計這種成長將在整個市場預測期內持續下去。

不孕症發生率的上升是推動全球體外受精（IVF）服務市場成長的關鍵因素。不孕率的增加可能與近幾十年來出現的一系列社會、經濟和健康相關因素有關。

根據 2024 年 10 月的 Cofertility資料，不孕症是一個重大的全球健康問題，影響著全球約六分之一的人。這項統計數據凸顯了不孕症的普遍存在是一個超越地理和社會經濟界線的主要問題。大約 17.5% 的成年人在一生中的某個階段經歷過不孕不育。

這相當於大約六分之一的人，顯示不孕不育是影響全球數百萬人的普遍問題。大約 12% 的女性在懷孕或生孩子方面遇到困難。 19% 的夫婦在無保護性交一年後無法懷孕。此外，10% 的夫婦在無保護性行為兩年後仍然無法懷孕，這表明長期不孕是許多人的常見經歷。

不孕症發病率的增加與體外受精服務的需求增加有直接關係。隨著越來越多的夫婦尋求受孕協助，生育診所的患者數量不斷增加，服務範圍也不斷擴大。輔助生殖技術的利用以每年 5% 至 10% 的速度成長，反映出人們越來越依賴 IVF 作為不孕症的可行解決方案。生殖技術的進步進一步推動了這一趨勢，提高了成功率並使治療更有效。

此外，產業技術進步和創新發布的關鍵參與者將推動體外受精 (IVF) 服務市場的成長。例如，2023年9月，德國達姆施塔特默克公司啟動了生育福利計劃，旨在為接受生育治療的員工提供財務支持。這項措施反映了公司致力於提高員工福祉並解決與不孕症相關的情感和經濟負擔。

此外，2023 年 9 月，生殖科技公司 AIVF 在巴西戈亞尼亞的 Perfetto 診所推出了首個人工智慧驅動的 IVF 作業系統。這項重大擴張是為了滿足全球對體外受精治療日益成長的需求，旨在提高生育護理的效率和效果。所有這些因素都需要全球體外受精（IVF）服務市場。

此外，對採用先進技術的需求不斷成長，有助於全球體外受精（IVF）服務市場的擴張。

體外受精程序的高成本

體外受精程序的高成本將阻礙全球體外受精（IVF）服務市場的成長。全球體外受精 (IVF) 服務市場受到阻礙其成長和可及性的各種限制的嚴重影響。其中，高昂的治療費用、經濟負擔和倫理考量是最重要的。

根據 2022 年 10 月的 Fierce Healthcare 新聞，與不孕症治療（尤其是體外受精 (IVF)）相關的財務負擔是巨大的。在美國，一個 IVF 週期的費用通常約為 12,000 美元，但如果考慮到藥物和其他手術，這個數字可能會上升到 25,000 美元。鑑於許多患者在第一次嘗試時未能懷孕，他們通常會接受平均三到五個週期的多個週期，以增加成功的機會。

許多患者發現他們需要多個 IVF 週期才能成功懷孕。研究表明，每位患者平均接受約 2.3 至 2.7 個週期，隨著時間的推移，累積費用可能超過 50,000 美元。每個額外周期的平均費用約為 6,955 美元，進一步加劇了夫婦的經濟壓力5。在生育治療保險覆蓋範圍有限或不存在的地區，這種情況尤其具有挑戰性。由於缺乏涵蓋體外受精治療的綜合保險政策，許多夫婦面臨巨額自付費用。試管嬰兒的費用根據地理位置的不同可能會大不相同。例如，與農村地區的診所相比，主要大都市地區的診所收取的費用可能更高。

因此，上述因素可能限制全球體外受精（IVF）服務市場的潛在成長。

In Vitro Fertilization (IVF) services is a medical procedure that facilitates fertilization by combining an egg with sperm outside the body, typically in a laboratory environment. The term "in vitro," which translates to "in glass," signifies that the fertilization process occurs in a controlled setting rather than within the human body. The IVF process generally consists of several key steps including ovarian stimulation, egg retrieval, fertilization, embryo culture, and embryo transfer.

IVF services are commonly employed to address various causes of infertility, including advanced maternal age, blocked fallopian tubes, male factor infertility, endometriosis, and unexplained infertility. This procedure has become a vital option for many couples seeking to conceive when faced with challenges related to fertility. These factors have expanded the global in vitro fertilization (IVF) services market.

Market Dynamics: Drivers & Restraints

Increasing Incidence of Infertility

The increasing incidence of infertility is significantly driving the growth of the global in vitro fertilization (IVF) services market, which is expected to continue throughout the market forecast period.

The rising incidence of infertility is a key factor driving the growth of the global in vitro fertilization (IVF) services market. This increase in infertility rates can be linked to a range of social, economic, and health-related factors that have developed over recent decades.

As per the Cofertility data in October 2024, infertility is a significant global health issue, affecting approximately 1 in 6 individuals worldwide. This statistic highlights the prevalence of infertility as a major concern that transcends geographical and socioeconomic boundaries. About 17.5% of the adult population experiences infertility at some point in their lives.

This translates to roughly 1 in 6 individuals, indicating that infertility is a widespread issue affecting millions globally. Approximately 12% of women encounter difficulties either becoming pregnant or carrying a child to term. 19% of all couples are unable to conceive after one year of unprotected sexual intercourse. Furthermore, 10% of couples remain unable to conceive after two years of unprotected sex, indicating that prolonged infertility is a common experience for many.

The increasing incidence of infertility is directly linked to a heightened demand for IVF services. As more couples seek assistance in conceiving, fertility clinics are experiencing a rise in patient volumes and expanding their range of service offerings. The utilization of assisted reproductive technologies has been growing at an annual rate of 5% to 10%, reflecting a growing reliance on IVF as a viable solution for infertility. This trend is further bolstered by advancements in reproductive technology that enhance success rates and make treatments more effective.

Furthermore, key players in the industry technological advancements, and innovative launches that would drive this in vitro fertilization (IVF) services market growth. For instance, in September 2023, Merck KGaA, Darmstadt, Germany, launched a Fertility Benefits Program aimed at providing financial support for employees undergoing fertility treatments. This initiative reflects the company's commitment to enhancing employee well-being and addressing the emotional and financial burdens associated with infertility.

Also, in September 2023, AIVF, a reproductive technology company, launched the first AI-powered IVF operating system at the Perfetto Clinic in Goiania, Brazil. This significant expansion comes in response to the increasing global demand for IVF treatments and aims to enhance the efficiency and effectiveness of fertility care. All these factors demand the global in vitro fertilization (IVF) services market.

Moreover, the rising demand for the adoption of advanced technologies contributes to the global in vitro fertilization (IVF) services market expansion.

High Costs of IVF Procedures

The high costs of IVF procedures will hinder the growth of the global in vitro fertilization (IVF) services market. The global in vitro fertilization (IVF) services market is significantly impacted by various restraints that hinder its growth and accessibility. Among these, high treatment costs, financial burdens, and ethical considerations are paramount.

As per Fierce Healthcare news in October 2022, the financial burden associated with infertility treatments, particularly In Vitro Fertilization (IVF), is substantial. In the U.S., a single IVF cycle typically costs around $12,000, but this figure can escalate to $25,000 when factoring in medications and additional procedures. Given that many patients do not achieve pregnancy on their first attempt, they often undergo multiple cycles averaging between three to five cycles to increase their chances of success.

Many patients find that they require multiple IVF cycles to achieve a successful pregnancy. Research indicates that the average patient undergoes approximately 2.3 to 2.7 cycles, leading to cumulative expenses that can exceed $50,000 over time. Each additional cycle incurs an average cost of around $6,955, further compounding the financial strain on couples5. This situation is particularly challenging in regions where insurance coverage for fertility treatments is limited or nonexistent. Many couples face significant out-of-pocket expenses due to the lack of comprehensive insurance policies that cover IVF treatments. The cost of IVF can vary significantly based on geographic location. For instance, clinics in major metropolitan areas may charge higher rates compared to those in rural settings.

Thus, the above factors could be limiting the global in vitro fertilization (IVF) services market's potential growth.

Segment Analysis

The global in vitro fertilization (IVF) services market is segmented based on treatment type, end-user, and region.

Treatment Type:

The conventional IVF segment is expected to dominate the global in vitro fertilization (IVF) services market share

The conventional IVF segment holds a major portion of the global in vitro fertilization (IVF) services market share and is expected to continue to hold a significant portion of the global in vitro fertilization (IVF) services market share during the forecast period.

Conventional IVF (c-IVF) remains one of the most widely practiced assisted reproductive technology (ART) methods globally. However, recent years have seen a significant decline in the number of c-IVF procedures, largely due to the increasing preference for intracytoplasmic sperm injection (ICSI), particularly in cases of non-male-related infertility.

According to the NCBI research study in September 2022, infertility affects approximately 48.5 million couples, translating to around 186 million individuals globally. As a result, assisted reproductive technology (ART) has become the most widely recommended solution for those seeking reproductive assistance. Over the past four decades, significant advancements have been made in this field. According to the International Committee for Monitoring ART (ICMART), more than 8 million babies have been born as a result of ART procedures and other advanced fertility treatments since the birth of the first test-tube baby.

Key advancements in ART include improvements in controlled ovarian hyperstimulation, oocyte retrieval techniques, embryonic culture conditions, and freezing procedures, all of which have significantly enhanced human fertility treatments.

One of the most notable technological innovations in ART is intracytoplasmic sperm injection (ICSI), developed to address the low and unpredictable fertilization rates often encountered with conventional in vitro fertilization (c-IVF), particularly in cases involving poor sperm parameters. However, over the last two decades, there has been a rapid increase in the adoption of ICSI, raising questions about its appropriateness in various clinical situations. These factors have solidified the segment's position in the global in vitro fertilization (IVF) services market.

Geographical Analysis

North America is expected to hold a significant position in the global in vitro fertilization (IVF) services market share

As infertility becomes more prevalent, the demand for IVF services continues to rise. Couples facing difficulties in conceiving are increasingly turning to assisted reproductive technologies as viable options. The growing awareness and acceptance of IVF as a solution contribute significantly to market growth.

Infertility has become a significant health issue, affecting approximately 1 in 8 couples in the United States. This statistic highlights the prevalence of infertility, which can result from various factors including age, lifestyle, and medical conditions. Infertility affects a significant portion of the population, with over 10% of women and around 9% of men experiencing infertility issues in the U.S. This rising prevalence drives demand for IVF services as couples seek effective reproductive solutions.

Continuous improvements in reproductive technologies, including controlled ovarian hyperstimulation and embryo culture techniques, have enhanced the success rates of IVF procedures. Innovations such as intracytoplasmic sperm injection (ICSI) have also contributed to better outcomes, especially in cases of male infertility.

Furthermore, key players in the industry have innovative launches and technological advancements that would drive this in vitro fertilization (IVF) services market growth. For instance, in October 2024, Cook Medical announced the launch of its NestVT vitrification device for In Vitro Fertilization (IVF) in the United States. This innovative device is designed to enhance the safety and efficiency of handling embryos and oocytes during the critical processes of vitrification, cryo-storage, and relocation.

Also, in October 2022, Alife Health launched an innovative AI technology aimed at enhancing In Vitro Fertilization (IVF) treatment outcomes while simultaneously lowering costs. This advancement is part of Alife's mission to modernize and personalize the IVF process through the use of artificial intelligence and data-driven insights.

Thus, the above factors are consolidating the region's position as a dominant force in the global in vitro fertilization (IVF) services market.

Asia Pacific holds the fastest pace in the global in vitro fertilization (IVF) services market and is expected to hold most of the market share.

The rise in infertility cases among both men and women is a significant driver for the IVF market. Factors such as sedentary lifestyles, poor dietary habits, and increased exposure to environmental pollutants contribute to this trend. Common conditions like polycystic ovary syndrome (PCOS) and endometriosis further exacerbate infertility rates, leading many couples to seek assisted reproductive technologies like IVF.

Rapid advancements in IVF technologies have significantly improved success rates and treatment effectiveness. Innovations such as controlled ovarian hyperstimulation, embryo culture techniques, and intracytoplasmic sperm injection (ICSI) have enhanced overall outcomes for IVF procedures, making them more appealing to couples facing infertility. Many governments in the region are introducing supportive policies and funding initiatives aimed at promoting reproductive health services, including IVF. This financial backing helps reduce the costs associated with fertility treatments, making them more accessible to a broader population.

India has experienced a notable surge in In Vitro Fertilization (IVF) services, driven by several interrelated factors. This growth reflects changing societal norms, economic conditions, and increasing awareness surrounding fertility treatments.

Furthermore, key players in the industry introducing innovative technologies and government initiatives that would drive this global in vitro fertilization (IVF) services market growth. For instance, In April 2023, Bengaluru-based DYU Healthcare introduced Smart IVF technology, which leverages artificial intelligence (AI) and advanced algorithms to enhance the in-vitro fertilization (IVF) process. This innovative approach aims to significantly improve the chances of successful pregnancies while providing personalized treatment plans tailored to the unique needs of each patient.

Also, in October 2023, the Telangana government inaugurated the first state-run In Vitro Fertilization (IVF) facility at Gandhi Hospital in Secunderabad, marking a significant advancement in public healthcare services for childless couples. This initiative is particularly noteworthy as it provides IVF services free of cost, which include comprehensive investigations, treatment, hormonal therapy, and follow-up care.

Thus, the above factors are consolidating the region's position as the fastest-growing force in the global in vitro fertilization (IVF) services market.

Competitive Landscape

The major global players in the in vitro fertilization (IVF) services market include Virtus Health, Genea Pty Limited., Aksigen, Shady Grove Fertility, New Hope Fertility Clinic, Boston IVF, Cyprus IVF Centre, EUVITRO S.L.U., Fertility Centers of Illinois, and Houston Fertility Center among others.

Key Developments

In September 2024, MGM Healthcare launched its Varam IVF Centre in Chennai, which aims to provide comprehensive and advanced fertility treatments. This initiative is designed to cater to couples facing infertility challenges by combining specialized medical expertise with state-of-the-art technology and a range of ancillary services, all within one facility.

Why Purchase the Report?

Pipeline & Innovations: Reviews ongoing clinical trials, and product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
Post-market Surveillance: Uses post-market data to enhance product safety and access.
Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global in vitro fertilization (IVF) services market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
Supply Chain: Distribution and Supply Chain Managers.
Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
Academic & Research: Academic Institutions.

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Treatment Type
3.2. Snippet by Connectivity Type
3.3. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Increasing Incidence of Infertility
- 4.1.2. Restraints
  - 4.1.2.1. High Costs of IVF Procedures
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Patent Analysis
5.5. Regulatory Analysis
5.6. SWOT Analysis
5.7. Unmet Needs

6. By Treatment Type

6.1. Introduction
- 6.1.1. Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
- 6.1.2. Market Attractiveness Index, By Treatment Type
6.2. Conventional IVF *
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Intracytoplasmic Sperm Injection (ICSI)
6.4. Mini IVF
6.5. Natural Cycle IVF
6.6. Fresh Cycle IVF
6.7. Frozen Embryo Transfer (FET)
6.8. Others

7. By End-User

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 7.1.2. Market Attractiveness Index, By End-User
7.2. Fertility Clinics*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Hospitals
7.4. Others

8. By Region

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 8.1.2. Market Attractiveness Index, By Region
8.2. North America
- 8.2.1. Introduction
- 8.2.2. Key Region-Specific Dynamics
- 8.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
- 8.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 8.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 8.2.5.1. U.S.
  - 8.2.5.2. Canada
  - 8.2.5.3. Mexico
8.3. Europe
- 8.3.1. Introduction
- 8.3.2. Key Region-Specific Dynamics
- 8.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
- 8.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 8.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 8.3.5.1. Germany
  - 8.3.5.2. U.K.
  - 8.3.5.3. France
  - 8.3.5.4. Spain
  - 8.3.5.5. Italy
  - 8.3.5.6. Rest of Europe
8.4. South America
- 8.4.1. Introduction
- 8.4.2. Key Region-Specific Dynamics
- 8.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
- 8.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 8.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 8.4.5.1. Brazil
  - 8.4.5.2. Argentina
  - 8.4.5.3. Rest of South America
8.5. Asia-Pacific
- 8.5.1. Introduction
- 8.5.2. Key Region-Specific Dynamics
- 8.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
- 8.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 8.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 8.5.5.1. China
  - 8.5.5.2. India
  - 8.5.5.3. Japan
  - 8.5.5.4. South Korea
  - 8.5.5.5. Rest of Asia-Pacific
8.6. Middle East and Africa
- 8.6.1. Introduction
- 8.6.2. Key Region-Specific Dynamics
- 8.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
- 8.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

9. Competitive Landscape

9.1. Competitive Scenario
9.2. Market Positioning/Share Analysis
9.3. Mergers and Acquisitions Analysis

10. Company Profiles

10.1. Virtus Health*
- 10.1.1. Company Overview
- 10.1.2. Product Portfolio and Description
- 10.1.3. Financial Overview
- 10.1.4. Key Developments
10.2. Genea Pty Limited.
10.3. Aksigen
10.4. Shady Grove Fertility
10.5. New Hope Fertility Clinic
10.6. Boston IVF
10.7. Cyprus IVF Centre
10.8. EUVITRO S.L.U.
10.9. Fertility Centers of Illinois
10.10. Houston Fertility Center